Advertisement
MO BIO
MO BIO

News & Opinion

» cell & molecular biology, ecology and opinion

Covering the life sciences inside and out

Most Recent

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: Fish Transport Fukushima Radiation

Fish Transport Fukushima Radiation

By | May 28, 2012

Radioactive particles from the Fukushima nuclear disaster provide an unexpected way to track migratory marine species.

5 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

0 Comments

image: Opinion: Saving Species through Economics

Opinion: Saving Species through Economics

By | May 21, 2012

Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.

4 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

image: Synchronized Clocks

Synchronized Clocks

By | May 16, 2012

Researchers identify the first circadian clock component conserved across all three domains of life.

1 Comment

image: How Prawns Lure Prey

How Prawns Lure Prey

By | May 15, 2012

Orange-loving Trinidad guppies are curiously attracted to orange spots on prawn pincers, which may make it easier for the predators to snatch them up.

1 Comment

image: Behavior Brief

Behavior Brief

By | May 15, 2012

A round-up of recent discoveries in behavior research

5 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
BD Biosciences
BD Biosciences

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
Advertisement
Molecular Devices
Molecular Devices
Life Technologies